Fishy Whales
Security

NBIX · Neurocrine Biosciences Inc

40 institutional holder(s) · 6 congressional trade(s)
← Funds
Neurocrine Biosciences Inc is a company in the Health Care sector, identified from SEC filings. It is held by 14 of 30 tracked funds in the latest quarter and traded by 2 members of Congress in disclosed filings.

Institutional holders

13F
FundValueShares
Vanguard Group $1.27B8,948,236
BlackRock $1.23B7,270,849
Vanguard Portfolio Management $838.3M4,974,083
Vanguard Capital Management $766M4,545,339
State Street $739.1M4,385,598
BlackRock $573.8M3,404,672
Renaissance Technologies $393.7M2,335,897
Two Sigma Investments $349.9M2,076,260
Geode Capital Management $243.6M1,722,305
BlackRock $125.1M742,122
Vanguard Group $87.9M619,873
BlackRock $69.3M411,089
BlackRock $65.5M388,505
BlackRock $61.1M362,709
Geode Capital Management $57.5M405,177
Morgan Stanley $55.7M330,714
Morgan Stanley $46.2M274,040
BlackRock $41.8M248,080
Fidelity $40.6M240,612
BlackRock $39.9M236,484
Bank of America $35.7M212,085
Bridgewater Associates $34.7M205,677
BlackRock $32.8M194,763
Bank of America $32.1M190,721
Morgan Stanley $32.1M190,219
Morgan Stanley $31M184,111
BlackRock $28.6M169,754
BlackRock $20.7M122,611
Morgan Stanley $16M95,138
Bank of America $15.1M89,871
Morgan Stanley $13.3M79,051
Bank of America $12.7M75,575
BlackRock $12.7M75,228
Morgan Stanley $10.6M62,715
Fidelity $9.4M55,910
Morgan Stanley $8M47,482
Morgan Stanley $7.3M43,222
Vanguard Group $7M49,649
Bank of America $6.1M36,383
Vanguard Group $6.1M42,897

Congressional trades

STOCK Act
MemberTypeDate
Lisa McClain sell 06/17/2025
Lisa McClain buy 06/11/2025
Michael McCaul sell 12/16/2022
Michael McCaul sell 01/28/2022
Michael McCaul sell 12/21/2021
Michael McCaul sell 12/14/2021